{"id":"https://openalex.org/W2139255064","doi":"https://doi.org/10.1177/1352458507086667","title":"Modeling the cost-effectiveness of a new treatment for MS (natalizumab) compared with current standard practice in Sweden","display_name":"Modeling the cost-effectiveness of a new treatment for MS (natalizumab) compared with current standard practice in Sweden","publication_year":2008,"publication_date":"2008-06-01","ids":{"openalex":"https://openalex.org/W2139255064","doi":"https://doi.org/10.1177/1352458507086667","mag":"2139255064","pmid":"https://pubmed.ncbi.nlm.nih.gov/18566030"},"language":"en","primary_location":{"id":"doi:10.1177/1352458507086667","doi":"https://doi.org/10.1177/1352458507086667","is_oa":false,"landing_page_url":"https://doi.org/10.1177/1352458507086667","pdf_url":null,"source":{"id":"https://openalex.org/S136332993","display_name":"Multiple Sclerosis Journal","issn_l":"1352-4585","issn":["1352-4585","1477-0970"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Multiple Sclerosis Journal","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5045027748","display_name":"Gisela Kobelt","orcid":"https://orcid.org/0000-0003-2113-3665","observed_orcids":["https://orcid.org/0000-0003-2113-3665"]},"institutions":[{"id":"https://openalex.org/I187531555","display_name":"Lund University","ror":"https://ror.org/012a77v79","country_code":"SE","type":"education","lineage":["https://openalex.org/I187531555"]}],"countries":["SE"],"is_corresponding":true,"raw_author_name":"G Kobelt","raw_affiliation_strings":["European Health Economics, Mulhouse, France; Department of Orthopedics, Lund University, Sweden,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"European Health Economics, Mulhouse, France; Department of Orthopedics, Lund University, Sweden,","institution_ids":["https://openalex.org/I187531555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010639674","display_name":"Jenny Berg","orcid":"https://orcid.org/0000-0002-5994-6816","observed_orcids":["https://orcid.org/0000-0002-5994-6816"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J Berg","raw_affiliation_strings":["i3/Innovus, Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"i3/Innovus, Stockholm, Sweden","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047724241","display_name":"Peter Lindgren","orcid":"https://orcid.org/0000-0002-8238-8189","observed_orcids":["https://orcid.org/0000-0002-8238-8189"]},"institutions":[{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"P Lindgren","raw_affiliation_strings":["i3/Innovus, Stockholm, Sweden; Department of Cardiovascular Epidemiology, Institute of Environmental Medicine, Karolinska Institute, Solna, Sweden","i3/Innovus, Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"i3/Innovus, Stockholm, Sweden; Department of Cardiovascular Epidemiology, Institute of Environmental Medicine, Karolinska Institute, Solna, Sweden","institution_ids":["https://openalex.org/I28166907"]},{"raw_affiliation_string":"i3/Innovus, Stockholm, Sweden","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113967524","display_name":"Bj\u00f6rn Jonsson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I123387679","display_name":"Uppsala University","ror":"https://ror.org/048a87296","country_code":"SE","type":"education","lineage":["https://openalex.org/I123387679"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"B Jonsson","raw_affiliation_strings":["Department of Women's and Children's Health, Uppsala University, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Women's and Children's Health, Uppsala University, Sweden","institution_ids":["https://openalex.org/I123387679"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013421216","display_name":"Leszek Stawiarz","orcid":"https://orcid.org/0000-0003-1018-3763","observed_orcids":["https://orcid.org/0000-0003-1018-3763"]},"institutions":[{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"L Stawiarz","raw_affiliation_strings":["Department of Clinical Neuroscience, Karolinska Institute, Huddinge, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Neuroscience, Karolinska Institute, Huddinge, Sweden","institution_ids":["https://openalex.org/I28166907"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5053300118","display_name":"Jan A. Hillert","orcid":"https://orcid.org/0000-0002-7386-6732","observed_orcids":["https://orcid.org/0000-0002-7386-6732"]},"institutions":[{"id":"https://openalex.org/I28166907","display_name":"Karolinska Institutet","ror":"https://ror.org/056d84691","country_code":"SE","type":"education","lineage":["https://openalex.org/I28166907"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"J Hillert","raw_affiliation_strings":["Department of Clinical Neuroscience, Karolinska Institute, Huddinge, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Neuroscience, Karolinska Institute, Huddinge, Sweden","institution_ids":["https://openalex.org/I28166907"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5045027748"],"corresponding_institution_ids":["https://openalex.org/I187531555"],"apc_list":{"value":4400,"currency":"USD","value_usd":4400},"apc_paid":null,"fwci":6.6389,"has_fulltext":false,"cited_by_count":51,"citation_normalized_percentile":{"value":0.96215072,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"14","issue":"5","first_page":"679","last_page":"690"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.8173999786376953,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.8173999786376953,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":0.17990000545978546,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/natalizumab","display_name":"natalizumab","score":0.9760000109672546},{"id":"https://openalex.org/keywords/multiple-sclerosis","display_name":"multiple sclerosis","score":0.996999979019165},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.9760000109672546},{"id":"https://openalex.org/keywords/disease-modifying-drugs","display_name":"disease-modifying drugs","score":0.996999979019165},{"id":"https://openalex.org/keywords/relapsing-remitting-multiple-sclerosis","display_name":"relapsing-remitting multiple sclerosis","score":0.9490000009536743},{"id":"https://openalex.org/keywords/expanded-disability-status-scale","display_name":"Expanded Disability Status Scale","score":0.9459999799728394},{"id":"https://openalex.org/keywords/functional-disability","display_name":"functional disability","score":0.6579999923706055},{"id":"https://openalex.org/keywords/quality-adjusted-life-years","display_name":"quality-adjusted life years","score":0.7850000262260437},{"id":"https://openalex.org/keywords/affirm-trial","display_name":"AFFIRM trial","score":0.6309999823570251},{"id":"https://openalex.org/keywords/health-care-costs","display_name":"health care costs","score":0.5019999742507935},{"id":"https://openalex.org/keywords/sweden","display_name":"Sweden","score":0.5090000033378601}],"concepts":[{"id":"https://openalex.org/C2781004633","wikidata":"https://www.wikidata.org/wiki/Q386119","display_name":"Natalizumab","level":3,"score":0.9044802188873291},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7988331913948059},{"id":"https://openalex.org/C3019080777","wikidata":"https://www.wikidata.org/wiki/Q1754768","display_name":"Cost effectiveness","level":2,"score":0.6615315675735474},{"id":"https://openalex.org/C23131810","wikidata":"https://www.wikidata.org/wiki/Q818574","display_name":"Observational study","level":2,"score":0.6499890089035034},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.6072927117347717},{"id":"https://openalex.org/C64332521","wikidata":"https://www.wikidata.org/wiki/Q614165","display_name":"Quality-adjusted life year","level":3,"score":0.5967482328414917},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.518648087978363},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.49345484375953674},{"id":"https://openalex.org/C201903717","wikidata":"https://www.wikidata.org/wiki/Q1778788","display_name":"Cohort study","level":2,"score":0.4750373661518097},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.4343879520893097},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4268721342086792},{"id":"https://openalex.org/C2780892749","wikidata":"https://www.wikidata.org/wiki/Q929518","display_name":"Expanded Disability Status Scale","level":3,"score":0.42144298553466797},{"id":"https://openalex.org/C2780640218","wikidata":"https://www.wikidata.org/wiki/Q8277","display_name":"Multiple sclerosis","level":2,"score":0.4190506935119629},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1902129054069519},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.12089821696281433},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0855238139629364},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000069442","descriptor_name":"Natalizumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003362","descriptor_name":"Cost-Benefit Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008390","descriptor_name":"Markov Chains","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012042","descriptor_name":"Registries","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013548","descriptor_name":"Sweden","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D016527","descriptor_name":"Drug Costs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017048","descriptor_name":"Health Care Costs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017059","descriptor_name":"Models, Econometric","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D020529","descriptor_name":"Multiple Sclerosis, Relapsing-Remitting","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D020529","descriptor_name":"Multiple Sclerosis, Relapsing-Remitting","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D020529","descriptor_name":"Multiple Sclerosis, Relapsing-Remitting","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1177/1352458507086667","doi":"https://doi.org/10.1177/1352458507086667","is_oa":false,"landing_page_url":"https://doi.org/10.1177/1352458507086667","pdf_url":null,"source":{"id":"https://openalex.org/S136332993","display_name":"Multiple Sclerosis Journal","issn_l":"1352-4585","issn":["1352-4585","1477-0970"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Multiple Sclerosis Journal","raw_type":"journal-article"},{"id":"pmid:18566030","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18566030","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Multiple sclerosis (Houndmills, Basingstoke, England)","raw_type":"Journal Article"},{"id":"pmh:oai:lup.lub.lu.se:412f4217-ce71-4274-87fa-056bda70d06a","doi":null,"is_oa":false,"landing_page_url":"https://lup.lub.lu.se/record/1168668","pdf_url":null,"source":{"id":"https://openalex.org/S4306400536","display_name":"Lund University Publications (Lund University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I187531555","host_organization_name":"Lund University","host_organization_lineage":["https://openalex.org/I187531555"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"ISSN: 1477-0970","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":30,"referenced_works":["https://openalex.org/W146365059","https://openalex.org/W1480287350","https://openalex.org/W1967507425","https://openalex.org/W1975104912","https://openalex.org/W2000665481","https://openalex.org/W2001446148","https://openalex.org/W2018622875","https://openalex.org/W2045920400","https://openalex.org/W2053199643","https://openalex.org/W2065155761","https://openalex.org/W2103758700","https://openalex.org/W2106467284","https://openalex.org/W2112165124","https://openalex.org/W2131833895","https://openalex.org/W2139367012","https://openalex.org/W2139855695","https://openalex.org/W2145185401","https://openalex.org/W2154217034","https://openalex.org/W2165547142","https://openalex.org/W2169098250","https://openalex.org/W2171614089","https://openalex.org/W2326826867","https://openalex.org/W2340533542","https://openalex.org/W2404245847","https://openalex.org/W2417331852","https://openalex.org/W2473786944","https://openalex.org/W2704729794","https://openalex.org/W4210548604","https://openalex.org/W4238307484","https://openalex.org/W4299159248"],"related_works":["https://openalex.org/W4210407108","https://openalex.org/W1988100480","https://openalex.org/W2013062382","https://openalex.org/W2052014695","https://openalex.org/W2046712471","https://openalex.org/W3204914513","https://openalex.org/W2314073720","https://openalex.org/W4414326379","https://openalex.org/W2002890650","https://openalex.org/W3004043862"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"estimate":[2],"the":[3,75,87,99,123,131,148,171,188,192,201,216,222,238],"cost-effectiveness":[4,205],"of":[5,47,62,71,90,191,198,219],"a":[6,52,68,110,135,248,255],"new":[7],"treatment":[8,82,151,161],"(natalizumab)":[9],"for":[10,237],"multiple":[11],"sclerosis":[12],"(MS)":[13],"compared":[14],"with":[15,19,93,152,162,178],"current":[16,63,163,252],"standard":[17],"therapy":[18],"disease-modifying":[20],"drugs":[21],"(DMDs)":[22],"in":[23,56,74,98,114,139,229],"Sweden.":[24],"METHODS:":[25],"A":[26],"Markov":[27],"model":[28],"was":[29,49,65,154,180],"constructed":[30],"to":[31,85,187,214,226,251],"illustrate":[32],"disease":[33,88,95],"progression":[34],"based":[35,50,108],"on":[36,51,109],"functional":[37],"disability":[38],"(the":[39],"Expanded":[40],"Disability":[41],"Status":[42],"Scale":[43],"(EDSS)).":[44],"The":[45,60,232],"effectiveness":[46,61,197,228],"natalizumab":[48,153,179,199,220,241],"2-year":[53],"clinical":[54,224,230],"trial":[55,225],"942":[57],"patients":[58,73,92],"(AFFIRM).":[59],"DMDs":[64,253],"estimated":[66],"from":[67,81,130,221,254],"matched":[69],"sample":[70],"512":[72],"Stockholm":[76],"MS":[77],"registry.":[78],"Patients":[79],"withdrawing":[80],"were":[83,120,169],"assumed":[84],"follow":[86],"course":[89],"824":[91],"relapsing-remitting":[94],"at":[96,122,247],"onset":[97],"Ontario":[100],"natural":[101],"history":[102],"cohort.":[103],"Costs":[104],"and":[105,157,194,211],"utilities":[106],"are":[107,128,184],"recent":[111],"observational":[112,212],"study":[113],"1339":[115],"patients.":[116],"All":[117],"data":[118],"sets":[119],"available":[121],"patient":[124],"level.":[125],"Main":[126],"results":[127,234],"presented":[129],"societal":[132,256],"perspective,":[133],"over":[134],"20-year":[136],"time":[137,189],"frame,":[138],"2005":[140],"Euros":[141],"(euro1":[142],"=":[143],"9.25":[144],"SEK).":[145],"RESULTS:":[146],"In":[147],"base":[149],"case,":[150],"less":[155],"expensive":[156],"more":[158],"effective":[159],"than":[160],"DMDs.":[164],"When":[165],"only":[166,186],"healthcare":[167],"costs":[168],"considered,":[170,240],"cost":[172,250],"per":[173],"quality-adjusted":[174],"life":[175],"year":[176],"gained":[177],"euro38":[181],"145.":[182],"Results":[183],"sensitive":[185],"horizon":[190],"analysis":[193,206,233],"assumptions":[195],"about":[196],"beyond":[200],"trial.":[202],"CONCLUSIONS:":[203],"This":[204],"used":[207],"registry":[208],"data,":[209],"cohort":[210],"studies":[213],"extrapolate":[215],"efficacy":[217],"findings":[218],"AFFIRM":[223],"measure":[227],"practice.":[231],"suggest":[235],"that":[236],"population":[239],"provides":[242],"an":[243],"additional":[244],"health":[245],"benefit":[246],"similar":[249],"perspective.":[257]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":7}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}